Tag: heart-related problems
-
Xeljanz and Other JAK Inhibitors: Drug Safety Concerns Indicated by Recent FDA Actions
Possible FDA Advisory Committee Meeting for Xeljanz, Olumiant, and Rinvoq Mentioned by Commentators (Posted by Tom Lamb at Drug Injury Watch) Drug safety observers are watching the effects a recent FDA alert about Xeljanz-associated heart…
-
Xeljanz Has A New Drug Safety Issue, We Just Don’t Know How Significant It Is, Yet
February 2021 FDA Warning: Xeljanz Increased Risks for Serious Heart-related Problems and Cancers (Posted by Tom Lamb at Drug Injury Watch) During the past few years, there have been some Xeljanz drug…
-
Zofran: MDL No. 2657 Pending In Massachusetts With Judge Dennis Saylor Presiding Over These Drug Injury Birth Defects Lawsuits
Women Who Used Zofran Had Babies With Cleft Palate / Cleft Lip, Various Types Of Heart-Related Problems, And Other Congenital Malformations (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2015 the drug…